echemi logo
web-logo
slogan
homepage
Product
  • Product
  • Supplier
  • Inquiry

    My ECHEMI

    EN

    Home > Medical News > Medical Research Articles > BeiGene initiates the first human clinical trial of the TYK2 inhibitor BGB-23339 under development

    BeiGene initiates the first human clinical trial of the TYK2 inhibitor BGB-23339 under development

    • Last Update: 2022-01-04
    • Source: Internet
    • Author: User
    Tags

    acquisition press release

    factors 792
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com